$Aquestive Therapeutics (AQST.US)$ EARNINGS PREVIEW Aquestiv...
EARNINGS PREVIEW
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Aquestive Therapeutics Inc AQST.OQ AQST.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Aquestive Therapeutics Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," "hold" and "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aquestive Therapeutics Inc is $9.00, above its last closing price of $3.93.
Previous quarterly performance (using preferred earnings measure in US dollars).
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Aquestive Therapeutics Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," "hold" and "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aquestive Therapeutics Inc is $9.00, above its last closing price of $3.93.
Previous quarterly performance (using preferred earnings measure in US dollars).
-Reuters
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
476Followers
66Following
3033Visitors
Follow